L (2010-2018)


+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

LACTIC ACIDOSIS (Medical Condition Where Lactic Acid Builds Up in the Body, Resulting in a Too Low pH in the Blood)

LISTERIA (Type of Bacterial Food Poisoning)
LUPUS ERYTHEMATOSUS (See Also News Articles 2010-2018)
>LYME DISEASE + (See News Articles 2010-2018)

LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27159480

MEDICINAL USE OF CANNABIS: HISTORY AND CURRENT STATUS (full–undated ) http://www.parl.gc.ca/content/sen/committee/371/ille/presentation/kalant-e.htm
Decriminalization, demythologizing, desymbolizing and deemphasizing marijuana (full–1972) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1530369/pdf/amjph00730-0113.pdf
MARIJUANA RESCHEDULING PETITION RULING- JUDGE FRANCIS L. YOUNG (full–1988) http://www.druglibrary.org/SCHAFFER/Library/studies/YOUNG/index.html
Physicians’ attitudes toward the legalization of marijuana use (full–1989)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1026731/pdf/westjmed00130-0092.pdf
Economics of Cannabis Legalization (full–1993)  https://pdfs.semanticscholar.org/baf7/9244b58d0e69b237cef4264707e1311f14ff.pdf
Cannabis Hemp: The Invisible Prohibition Revealed (download–1997)  http://www.constitutionalcannabis.com/uploads/1/3/5/9/13590809/sots_web.pdf
Cannabis as medicine: time for the phoenix to rise? (full–1998)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1112898/?tool=pubmed
Feasibility of Industrial Hemp Production in the United States Pacific Northwest (link to PDF–1998) https://catalog.extension.oregonstate.edu/sb681
Providing medical marijuana: the importance of cannabis clubs (abst–1998)  http://www.ncbi.nlm.nih.gov/pubmed/9692380
Schedules of Controlled Substances: Rescheduling of the Food and Drug Administration
Approved Product Containing Synthetic Dronabinol [(-)-D9-(trans)-
Tetrahydrocannabinol] in Sesame Oil and Encapsulated in Soft Gelatin Capsules From
Schedule II to Schedule III (full–1999)  http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0702.htm
The Relationship between Research and Drug Policy in the United States (article–1999) http://cifas.us/analyses/laniel.html
Cannabis: Time for Scientific Evaluation of This Ancient Remedy? (full-2000)  http://journals.lww.com/anesthesia-analgesia/Fulltext/2000/02000/Cannabis__Time_for_Scientific_Evaluation_of_This.1.aspx
HISTORICAL AND CULTURAL USES OF CANNABIS AND THE CANADIAN “MARIJUANA CLASH” (full–2002)  http://www.parl.gc.ca/content/sen/committee/371/ille/library/spicer-e.htm
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis (full-2002)  http://www.maps.org/mmj/russo2002.pdf
Drug Reform Principles and Policy Debates: Harm Reduction Prospects for Cannabis in  Canada (abst–2003)  http://jod.sagepub.com/content/33/2/465.full.pdf+html
In the Matter of Lyle E Craker, Ph.D. Docket No. 05-16 (full–2007)  http://www.maps.org/research-archive/mmj/ALJfindings.PDF
Do Medical Cannabis Laws Encourage Cannabis Use? (abst-2007)  http://www.ijdp.org/article/S0955-3959%2806%2900211-8/abstract
Creating the cannabis user: a post-structuralist analysis of the re-classification of  cannabis in the United Kingdom (2004-2005) (abst–2007)  http://www.ncbi.nlm.nih.gov/pubmed/17689364
Scheduling process at DEA – the example of cannabidiol (abst–2008)  http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/711.1
Medicinal use of cannabis in the United States: Historical perspectives, current trends,  and future directions (full-2009)  http://www.letfreedomgrow.com/cmu/JOM_5-3-03-Carter.pdf
Medical Marijuana: are we ready? (article–2009)  https://sciencebasedmedicine.org/medical-marijuana-are-we-ready/
Medical Marijuana and the Law (full-2010)  http://content.nejm.org/cgi/content/full/362/16/1453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2080&resourcetype=HWCIT
The Budgetary Impact of Ending Drug Prohibition (news-link to PDF-2010)  http://www.cato.org/publications/white-paper/budgetary-impact-ending-drug-prohibition
Accommodating the medical use of marijuana: surveying the differing legal approaches  in Australia, the United States and Canada (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20329455
The intersection between cannabis and cancer in the United States (full–2011)  http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Cannabis and Its Derivatives: Review of Medical Use (full–2011)  http://www.jabfm.org/cgi/content/full/24/4/452
Medical marijuana: medical necessity versus political agenda (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/
What can we learn from the Dutch cannabis coffeeshop system? (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21906196
Medical grade cannabis (MGC): regulation mechanisms, the present situation around the  world and in Israel (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352285
Assessment of hospice health professionals’ knowledge, views, and experience with  medical marijuana (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22077541
Societal images of Cannabis use: comparing three countries (full–2012)  http://www.harmreductionjournal.com/content/pdf/1477-7517-9-21.pdf
Exploring the ecological association between crime and medical marijuana dispensaries  (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364319/
Medical marijuana laws in 50 states: Investigating the relationship between state  legalization of medical marijuana and marijuana use, abuse and dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251168/
Medical marijuana: the supremacy clause, federalism, and the interplay between state and federal laws (full–2012)  http://fas.org/sgp/crs/misc/R42398.pdf
Do medical marijuana laws increase marijuana use? Replication study and extension  (full–2012) http://www.annalsofepidemiology.org/article/S1047-2797%2811%2900372-3/fulltext
Using dopamine research to generate rational cannabinoid drug policy (abst–2012)  http://onlinelibrary.wiley.com/doi/10.1002/dta.1410/full
Design considerations for legalizing cannabis: lessons inspired by analysis of California’s  Proposition 19 (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/21985069
Estimating the economic value of British Columbia’s domestic cannabis market:  implications for provincial cannabis policy (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23085258
Therapeutic use of cannabis (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22479766
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
Medical Marijuana and Related Legal Aspects (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875249/
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
The Future of Marijuana in the United States (download-thesis–2013)  https://scholarsbank.uoregon.edu/xmlui/handle/1794/13615
Causes and Consequences of Expectation Trajectories: “High” on Optimism in a Public  Ballot Initiative (download–2013)  http://www.katesweeny.com/uploads/2/6/9/4/26944848/krizan__sweeny_2013_psysci.pdf
National-level drug policy and young people’s illicit drug use: A multilevel analysis of
the European Union (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23298650
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical  Cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Requiem for a CAMP: The life and death of a domestic U.S. drug war institution (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23561719
Effects of Schedule I drug laws on neuroscience research and treatment innovation  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756634
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and  beyond (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24180513
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A  time series analysis (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23867051
The DEA: Four Decades of Impeding And Rejecting Science (full–2014)  http://www.drugpolicy.org/sites/default/files/DPA-MAPS_DEA_Science_Final.pdf
Recommendations for Regulators – Cannabis Operations (full–2014)  http://www.a2la.org/appsweb/ASA_PFC_2016.pdf
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-
2006 (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Physicians, Medical Marijuana, and the Law (full–2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
The Legalization of Marijuana in Colorado: The Impact. Rocky Mountain HIDTA. The
Impact (full–2014)  http://www.rmhidta.org/html/August%202014%20Legalization%20of%20MJ%20in%20Colorado%20the%20Impact.pdf
Marijuana Policy in Colorado (full–2014)  http://object.cato.org/sites/cato.org/files/pubs/pdf/working-paper-24_2.pdf
Health Poll – Legalizing Marijuana (full–2014)  http://truvenhealth.com/Portals/0/NPR-Truven-Health-Poll/TRU_13728_0414_NPRPulseMarijuanaStudy.pdf
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use (full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
Correlates of intentions to use cannabis among US high school seniors in the case of  cannabis legalization (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071130/
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical  Marijuana Laws in the United States (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314612/
Cannabinoid modulation of drug reward and the implications of marijuana legalization  (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442758/
Political and medical views on medical marijuana and its future (link to download–2014)  https://www.researchgate.net/publication/259650013_Political_and_Medical_Views_on_Medical_Marijuana_and_its_Future
Big Marijuana — Lessons from Big Tobacco (link to download–2014) http://www.mentalhealthportland.org/wp-content/uploads/2014/09/Big-Marijuana-%e2%80%94-Lessons-from-Big-Tobacco.pdf
Medical marijuana: 4 experts on benefits vs. risks (article–2014)  https://www.elsevier.com/connect/medical-marijuana-4-experts-on-benefits-vs-risks
Marijuana Resource Center: State Laws Related to Marijuana (article–2014)  https://obamawhitehouse.archives.gov/ondcp/state-laws-related-to-marijuana
A Review and Critique of Dr. Sanjay Gupta’s Weed 2: Cannabis Madness on CNN (article–2014) http://cms.herbalgram.org/heg/volume11/04April/CNNGupataWEED2critique.html
Preferences for policy options for cannabis in an Australian general population: A
discrete choice experiment (abst–2014)  http://www.ijdp.org/article/S0955-3959(14)00066-8/fulltext
A dawning demand for a new cannabis policy: A study of Swedish online drug  discussions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24794114
Policy designs for cannabis legalization: starting with the eight Ps (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24853283
Cannabis depenalisation, drug consumption and crime – Evidence from the 2004 cannabis declassification in the UK (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0277953614003621
Cannabis policy reforms in the Americas: A comparative analysis of Colorado,  Washington, and Uruguay (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24970383
Cannabis social clubs in Belgium: Organizational strengths and weaknesses, and threats  to the model (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25179934
Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25181993
Does the legalization of medical marijuana increase completed suicide? (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24949839
Medical use of cannabis in Australia: “medical necessity” defences under current  Australian law and avenues for reform (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25087368
Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries (abst–2014) http://www.ijdp.org/article/S0955-3959(14)00173-X/abstract
Illegal drugs laws: clearing a 50-year-old obstacle to research (full–2015)  http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002047
Human rights, public health and medicinal cannabis use (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662098/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care,  and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup  (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Public opinion and medical cannabis policies: examining the role of underlying beliefs  and national medical cannabis policies (full–2015)  http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-015-0082-x
Medical marijuana’s public health lessons–implications for retail marijuana in Colorado  (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
U.S. Policy Responses to Calls for the Medical Use of Cannabis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553645/
Marijuana Legalization: Impact on Physicians and Public Health (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900958/
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015)  http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2016/03/MMJ_laws_Body-weight.pdf
Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675612/
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington  State and Victoria, Australia (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386529/
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s  Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana:  Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
In the weeds: a baseline view of cannabis use among legalizing states and their  neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Medicinal use of cannabis in Europe (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328738/
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and Two Years of Decriminalization (full–2015) https://www.crcr.org/wp-content/uploads/2016/04/The-Economic-Impact-of-Marijuana-Tax-and-Regulation-in-Colorado_031716.pdf
Do consumers substitute opium for hashish? An economic analysis of simultaneous  cannabinoid and opiate consumption in a legal regime (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655592/
Stigma among California’s Medical Marijuana Patients (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341951/
An economic analysis of different cannabis decriminalization scenarios (PDF–2015)  http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol27_sup1/dnb_vol27_sup1_309.pdf
Colorado Department of Revenue Enforcement Division – Marijuana Annual Update  (PDF–2015) http://www.warrenedson.com/upload/MMEDforms811.pdf
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update (link to PDF–2015) http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.long
I-502 Evaluation Plan and Preliminary Report on Implementation (Washington State  report) (link to PDF–2015)  http://www.wsipp.wa.gov/Reports/570
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to PDF-2015)  https://www.semanticscholar.org/paper/Do-Medical-Marijuana-Laws-Reduce-Addiction-and-Dea-PowellLiccardo/de1ed809a834f74de4cb902b7546bc3dc17ef231
Ending the U.S. government’s war on medical marijuana research (report–2015)  https://www.brookings.edu/research/ending-the-u-s-governments-war-on-medical-marijuana-research/
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Marijuana gears up for production high in US labs (article–2015)  http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Half-Baked — The Retail Promotion of Marijuana Edibles (article–2015)  http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context (article–2015)  http://www.beyondthebrain.net/blog/peaceful-feeling-or-up-in-smoke-medical-marijuana-in-medicolegal-context
The Impact of Legalizing and Regulating Weed: Issues with Study Design and Emerging  Findings in the USA (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26718590
Issues in the implementation and evolution of the commercial recreational cannabis  market in Colorado (abst–2015)  http://www.ijdp.org/article/S0955-3959(15)00354-0/abstract
Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of  Medical Cannabis Legalization (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26317379
Proving personal use: the admissibility of evidence negating intent to distribute  marijuana (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26030944
The impact of marijuana decriminalization on California drivers (abst–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(15)00108-8/fulltext
UNGASS 2016: Insights from Europe on the development of global cannabis policy and  the need for reform of the global drug policy regime (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26795703
Marijuana experiences, voting behaviors, and early perspectives regarding marijuana  legalization among college students from 2 states (abst–2015)  http://www.tandfonline.com/doi/full/10.1080/07448481.2015.1062769?src=recsys
Impacts of Changing Marijuana Policies on Alcohol Use in the United States (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700545/
Medical marijuana programs – Why might they matter for public health and why should  we better understand their impacts? (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721313/
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
The commercial focus of US cannabis regulation models should not close our eyes to  other options (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13383/full
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011 (full–2016) http://www.ijdp.org/article/S0955-3959(16)00038-4/fulltext
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and  Interest Prior to Program Launch (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
The relationship between cannabis use and measures of anxiety and depression in a  sample of college campus cannabis users and non-users post state legalization in  Colorado (full–2016) https://peerj.com/articles/2782/
A Public Health Framework for Legalized Retail Marijuana Based on the US Experience:
Avoiding a New Tobacco Industry (full–2016)   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038957/
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes  (full–2016) http://www.ijdp.org/article/S0955-3959(16)30334-6/fulltext
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United  States, 2002 to 2013 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957692/
Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in  Postwar Japan (full–2016)  http://online.liebertpub.com/doi/full/10.1089/can.2015.0011
Medicinal cannabis in Australia: the missing links (full–2016)  https://pdfs.semanticscholar.org/0a78/2bc09cea4e52007a16bd725ec3bee51e80b2.pdf
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010515/
The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging  market (download-full in English, abst in Spanish–2016)  http://www.adicciones.es/index.php/adicciones/article/view/807/832
American Attitudes toward Substance Use in the United States (click “Cancel” for link to download–2016) http://www.apnorc.org/projects/Pages/american-attitudes-toward-substance-use-in-the-united-states.aspx
Hemp as fibre and food? Regulatory developments and current issues (news/link to PDF–2016) http://apo.org.au/node/64033
The US as an example of how not to legalize marijuana? (download–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13498/pdf
Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement (click “Link out” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529905
Medical experts warn Australia’s understanding of medicinal cannabis lacking (link to interview transcript–2016) http://www.abc.net.au/radio/programs/worldtoday/medical-experts-warn-australias-understanding-of/7459420?pfmredir=ms
Cannabis in the United States (report–2016)  http://self.gutenberg.org/article/WHEBN0020566488/Cannabis%20in%20the%20United%20States
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access,  Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/
Dose of Reality: The Effect of State Marijuana Legalizations (report–2016)  http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Farming medical ganja in Jamaica (1st page–2016) http://www.ijdp.org/article/S0955-3959(16)30089-5/fulltext
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D (abst–2016) http://content.healthaffairs.org/content/35/7/1230.long
The Changing Drug Culture: Medical and Recreational Marijuana (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26881768
Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26944718
A common public health-oriented policy framework for cannabis, alcohol and tobacco in  Canada? (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26986906
Mitigation of Marijuana-Related Legal Harms to Youth in California (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26891110
Attitudes to legalizing cannabis use (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27037958
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
Considering marijuana legalization carefully: insights for other jurisdictions from  analysis for Vermont (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13289/abstract
Influence of legal status on the uptake of cannabis in young people (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27096170
Evaluating the public health impacts of legalizing recreational cannabis use in the USA  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27082374
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27285147
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Field observations of the developing legal recreational cannabis economy in Washington State (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27296756
MEDICINAL CANNABIS LAW REFORM IN AUSTRALIA (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27323630
Why it is probably too soon to assess the public health effects of legalisation of  recreational cannabis use in the USA (abst–2016)  http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30071-2/abstract
Cannabis consumption patterns among frequent consumers in Uruguay (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27397717
Qualitative research in Spanish cannabis social clubs: “The moment you enter the door,
you are minimising the risks” (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27461986
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the
reclassification of cannabis above 15% THC (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27471078
Cannabis clubs in Uruguay: The challenges of regulation (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27475713
Evidence-based policy? The re-medicalization of cannabis and the role of expert
committees in the UK, 1972-1982 (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27477790
The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation,
and challenges (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27596698
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally  Injured Drivers (abst–2016)  http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303426?journalCode=ajph
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail
Marijuana Outlets in Colorado (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27797687
The Normalization of Cannabis Use Among Bangladeshi and Pakistani Youth: A New Frontier for the Normalization Thesis? (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27849430
Is the Legalization of Marijuana Associated With Its Use by Adolescents? (abst–2016) http://www.tandfonline.com/doi/full/10.1080/10826084.2016.1223139?src=recsys
Attitudes towards drug policies in Latin America: Results from a Latin-American Survey  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27988428
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27420392
Underbanked: Cooperative Banking as a Potential Solution to the Marijuana-Banking  Problem (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27008718
US Traffic Fatalities, 1985–2014, and Their Relationship to Medical Marijuana Laws (abst–2016)  http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303577
Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey (full–2017)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7
Recreational Cannabis — Minimizing the Health Risks from Legalization (full–2017) http://www.nejm.org/doi/full/10.1056/NEJMp1614783
Physicians disagree on legal age for cannabis (full–2017)  http://www.cmaj.ca/content/189/4/E174.long
Two steps forward, one step back: current harm reduction policy and politics in the  United States (full–2017)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0157-y
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An  Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et  al., Respondents (download–2017) https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
Cannabis Guidelines (article–2017) https://cjon.ons.org/cjon/21/4/cannabis-guidelines
Cannabis: high time for evidence-based policies (editorial–2017)  http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30642-8/fulltext
Uruguay’s middle-ground approach to cannabis legalization (1st page–2017)  http://www.ijdp.org/article/S0955-3959(17)30055-5/fulltext
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More  Often in Response to Legalization Among U.S. Young Adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27976988
Public perceptions of arguments supporting and opposing recreational marijuana  legalization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28189806
Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory  practices in Spain, Belgium and Uruguay (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189980
Assessing the concordance between illicit drug laws on the books and drug law  enforcement: Comparison of three states on the continuum from “decriminalised” to
“punitive” (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28190670
Observations of the role of science in the United States medical cannabis state policies:  Lessons learnt (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28190671
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Community-level policy responses to state marijuana legalization in Washington State  (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28365192
A practical framework for regulating for-profit recreational marijuana in US States:  Lessons from Colorado and Washington (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28366598
From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in  Canada (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28377052
Cannabis decriminalization and the age of onset of cannabis use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28395168
State and National Contexts in Evaluating Cannabis Laws: A Case Study of Washington  State (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28458396
Support for marijuana legalization in the US state of Washington has continued to  increase through 2016 (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30171-0/fulltext
Bioethical analysis to the therapeutic use of Cannabis: Integrative review (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0969733017703699
Mapping regulatory models for medicinal cannabis: a matrix of options (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28553995
Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605305
Changes in undergraduates’ marijuana, heavy alcohol, and cigarette use following  legalization of recreational marijuana use in Oregon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28613454
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Mapping medical marijuana: state laws regulating patients, product safety, supply chains
and dispensaries, 2017 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28696583
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28705601
Argentina enacts first law on medical use of the cannabis plant. History and perspectives (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29044015
Crash Fatality Rates After Recreational Marijuana Legalization in Washington and  Colorado (abst–2017) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.303848
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing  relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views  Toward Legalization and Knowledge of Potential Harm (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28252456
Regulating Hemp and Cannabis-Based Products (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095577
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender,  2004-2013 (abst–2017) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Examining the relationship between medical cannabis laws and cardiovascular deaths in the US (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227828
The status of support for cannabis regulation in Uruguay 4 years after reform: Evidence  from public opinion surveys (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29230888
The three betrayals of the medical cannabis growing activist: From multiple victimhood  to reconstruction, redemption and activism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29287224
The effect of medical marijuana laws on the health and labor supply of older adults:  Evidence from the Health and Retirement Study (abst–2017)  http://www.nber.org/papers/w22688
Could cannabis liberalisation lead to wider changes in drug policies and outcomes? (full–2018) http://www.ijdp.org/article/S0955-3959(17)30324-9/fulltext
Medical use of cannabis and cannabinoids containing products – Regulations in Europe  and North America (abst–2018)  http://www.ejinme.com/article/S0953-6205(18)30001-3/fulltext
Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians’  Experiences, 2015-2016 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29161062
Medical cannabis: A forward vision for the clinician (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29377381
A “not-for-profit” regulatory model for legal recreational cannabis: Insights from the  regulation of gaming machine gambling in New Zealand (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29346087
Formal and Informal Control of Cannabis: Regular Users’ Experience (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29336651
Legislative Norms to Control Cannabis Use in the Light of Its Prevalence in Czech  Republic, Poland, Slovakia, and Hungary (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29346846
Consumer agency in cannabis supply – Exploring auto-regulatory documents of the  cannabis social clubs in Spain (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29367012
Medical use of cannabis and cannabinoids containing products – Regulations in Europe  and North America (abst–2018)  http://www.ejinme.com/article/S0953-6205(18)30001-3/fulltext

Legionnaires disease in cannabis smokers (full-2011) http://journal.publications.chestnet.org/article.aspx?articleid=1086681
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824

Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24463105
Minor oxygenated cannabinoids from high potency Cannabis sativa L. (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883105/

Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824

Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033442/
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde (abst–2010)  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1246364
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Role of the endocannabinoid system in alcoholic liver disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21525760
Endogenous cannabinoids in liver disease: Many darts for a single target (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in  patients with cirrhosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19840245
Endocannabinoids in liver disease (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24077/full
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via
cannabinoid type 1 (CB1) receptors in the regenerating liver (full–2011) http://www.pnas.org/content/108/15/6323.full
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis (full–2011)
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/pdf/nihms278422.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (full–2011) http://diabetes.diabetesjournals.org/content/60/4/1055.full
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration (full-2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.23779/full
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154437/
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance (full–2011) http://link.springer.com/article/10.1007/s00125-011-2274-6/fulltext.html
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24524/full
A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423243/
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011)  http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Cannabidiol, a Major Phytocannabinoid, as a Potent Atypical Inhibitor for Cytochrome
P450 2D6 (link to download–2011)  http://dmd.aspetjournals.org/content/early/2011/08/05/dmd.111.041384.long
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21930120
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21704641/abstract/Identification_of_cytochrome_P450_enzymes_responsible_for_metabolism_of_cannabidiol_by_human_liver_microsomes_
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes (abst–2011) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1269511
Effect of cannabidiol treatment in alimentary induced fatty liver (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21336842
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endo-cannabinoid and Apelin Systems (full–2012) http://jpet.aspetjournals.org/content/340/3/629.full
Δ(8) -Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (full–2012)  http://onlinelibrary.wiley.com/doi/10.1002/hep.25625/full
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharma-cological strategies and therapeutic possibilities (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC-MS/MS (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22931239
The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria (abst–2012)  http://www.springerlink.com/content/54jm40088728t0pn/
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry (abst–2012)  http://pubs.acs.org/doi/abs/10.1021/pr300683a
Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease (full–2013)  http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500039&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://scielo.isciii.es/scieloOrg/php/translate.php?pid=S0212-
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver (full–2013)  http://onlinelibrary.wiley.com/doi/10.1002/hep.26598/full
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome (full–2013) http://www.cell.com/cell-reports/fulltext/S2211-1247%2813%2900507-X
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839776/
Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 (full–2013) https://www.jstage.jst.go.jp/article/dmpk/28/4/28_DMPK-12-RG-129/_pdf
Cannabinoid signaling and liver therapeutics (full–2013) http://www.journal-of-hepatology.eu/article/S0168-8278%2813%2900212-2/fulltext
The role of endocannabinoids system in fatty liver disease and therapeutic potentials (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745655/
First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using
Human Hepatocytes and High-Resolution Mass Spectrometry (full–2013)  http://www.clinchem.org/content/59/11/1638.long
Dietary Linoleic Acid Elevates the Endocannabinoids 2-AG and Anandamide and  Promotes Weight Gain in Mice Fed a Low Fat Diet (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889814/
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2  Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23508466
US Patent Application 20130171145 – METHODS OF TREATING LIVER DISEASE (full–2013) http://www.freepatentsonline.com/y2013/0171145.html
Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23663762
Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23806692
Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extra-cellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076327
Functional relevance of the cannabinoid receptor 2 – heme oxygenase pathway: A novel target for the attenuation of portal hypertension (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24007798
Protective effect of cannabidiol against cadmium hepatotoxicity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23993482
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0032-1331948
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids
in inflammation-derived cardiovascular diseases (full–2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Non-alcoholic Fatty Liver Disease (full–2014) http://www.hindawi.com/journals/bmri/2014/502542/
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839256/
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127238/
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
Review article: the endocannabinoid system in liver disease, a potential therapeutic target (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/apt.12673/full
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (full–2014) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.12298
Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver micro-somes (link to PDF–2014) https://www.jstage.jst.go.jp/article/jts/39/6/39_815/_article
The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24459189
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/22828945
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Mechanism of endocannabinoids system in glucose metabolism of rats with chronic intermittent hypoxia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25146750
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24459189
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24974464

Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/06/jpet.114.220368.long
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury (full–2015) http://www.karger.com/Article/Pdf/430165
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i37/10704.htm
Bisdemethoxycurcumin Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2 (link to PDF–2015) http://www.mdpi.com/1420-3049/20/1/1277
Potent natural products and herbal medicines for treating liver fibrosis (full–2015) http://cmjournal.biomedcentral.com/articles/10.1186/s13020-015-0036-y
α/β Hydrolase Domain-Containing 6 (ABHD6) Degrades the Late Endosomal / Lysosomal Lipid Bis(monoacylglycero)phosphate (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705992/
Management of non-alcoholic fatty liver disease in 2015 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691699/
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells (full–2015) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=6466&path%5B%5D=17855
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites (full–2015) http://www.jleukbio.org/content/97/6/1049.long
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice (full–2015) http://www.jnutbio.com/article/S0955-2863(15)00021-2/fulltext
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury (full–2015) http://dmd.aspetjournals.org/content/43/11/1751.long
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609878/
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595882
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684344
Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25713910
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843798
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912618
CB1 receptor blockade counters age-induced insulin resistance and metabolic  dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921859/
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers (link to PDF–2016) http://www.spandidos-publications.com/10.3892/etm.2016.3036
The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159425
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism (full–2016) http://www.nature.com/articles/srep33302
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice (full–2016) http://diabetes.diabetesjournals.org/content/65/7/1824.long
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop (full–2016) http://press.endocrine.org/doi/10.1210/en.2015-1384?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes (full–2016) http://link.springer.com/article/10.1208%2Fs12248-016-0037-5
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961623/
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain  Endocannabinoid Levels (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418128/
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408584/
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid  anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic  syndrome (link to download–2016)  http://www.jlr.org/content/early/2016/02/17/jlr.M066308.long
In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708515302429
Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors (abst–2016) http://link.springer.com/article/10.1007/s00210-015-1181-7
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006291X16300833
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity (abst–2016) http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945822

Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028843
Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100518
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27155918
β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK  signaling by activating CB2 receptor in human HepG2 hepatocytes (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27234712
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27314752
FABP1 in wonderland (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.13664/abstract
Cannabinoids, inflammation, and fibrosis (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27435265
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.biochem.6b00446
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty
liver disease (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27863097
A systematic review of the effect of cannabidiol on cognitive function: Relevance to  schizophrenia (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0149763416304390
Using proteomics to discover novel biomarkers for fatty liver development and response  to CB1R antagonist treatment in an obese mouse model (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27928909
Bifidobacterium breve with α-linolenic acid alters the composition, distribution and  transcription factor activity associated with metabolism and absorption of fat (full–2017) http://www.nature.com/articles/srep43300
AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5′-DiphosphoGlucuronosyl-transferase Enzyme Activities in Human Liver Microsomes (full–2017) http://www.mdpi.com/1420-3049/22/3/443/htm
Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in
Rat Liver (full–2017) http://www.mdpi.com/1422-0067/18/9/1844/htm
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator  constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid dependent gut transit in ApoE-/- mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464855/
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1  Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in
Mouse Liver Fibrogenesis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625548/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by  D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response  to a high fat diet (click “Full Text” for download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28972119
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid  Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01504
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating  inflammation and metabolic dysregulation in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28107775
Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in  mice fed a high-caloric diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28347724
The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice  with nonalcoholic fatty liver disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28363784
Hepatotoxicity associated to synthetic cannabinoids use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28379600
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis (abst–2017) https://www.karger.com/Article/Abstract/462974
β-Amyrin, a pentacyclic triterpene, exhibits anti-fibrotic, anti-inflammatory, and antiapoptotic effects on dimethyl nitrosamine–induced hepatic fibrosis in male rats  (abst–2017) http://journals.sagepub.com/doi/full/10.1177/0960327116638727
The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a  translational study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28456476
CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats  treated with sitagliptin (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28599244
4-O′-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in  mice (abst–2017)  https://link.springer.com/article/10.1007%2Fs00109-017-1556-y
Protective effect of rimonabant, a canabinoid receptor 1 antagonist on nonalcoholic fatty liver disease in a rat model by modulating the hepatic expression of activin A and  follistatin (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28759733
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following  Developmental Chlorpyrifos Exposure in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28820005
Endocannabinoid Interaction with Human FABP1: Impact of T94A Variant (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28853554
Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and  Associated Diseases (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28913816
Dose – specific effects of Di-isononyl phthalate on the endocannabinoid system and on  liver of female zebrafish (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28938452
Differential tissue regulation of peroxisome proliferator-activated receptor α (PPARα)  and cannabinoid receptor 1 (CB1) gene transcription pathways by diethylene glycol  dibenzoate (DEGB): preliminary observations in a seabream (Sparus aurata) in vivo  model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28843100
Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse  effects in female Swiss mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0273230017304014?via%3Dihub
Effect of cannabinoid receptor-2 agonist AM1241 on platelet-derived growth factor  expression in the liver tissue of mice with hepatic fibrosis (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29325278 (abst in Chinese) http://zhgzbzz.yiigle.com/CN501113201711/1017666.htm?locale=zh_CN
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in  normal and high-fat fed male C57BL/6J mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor  system (abst–2018) http://www.ejinme.com/article/S0953-6205(18)30009-8/fulltext
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic  liver disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29341392
Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids  of female C57BL/6 mice (abst–2018)  https://www.sciencedirect.com/science/article/pii/S1388198117302044?via%

Effects of cannabis on lung function: a population-based cohort study (full-2010) http://erj.ersjournals.com/content/35/1/42.long
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana
use among individuals ingesting dronabinol (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users (full-2010)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461262/
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20565525
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037578/
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045206/
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260974/
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full–2011) (deceptive title) http://www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Effect of Cannabis sativa on Hematological Indices in Rats and Men (full–2011)  http://docsdrive.com/pdfs/ansinet/pjn/2011/313-316.pdf
Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained,  Monitored Abstinence (full–2011) http://clinchem.aaccjnls.org/content/57/8/1127.long
Obesity and Cannabis Use: Results From 2 Representative National Surveys (full–2011) http://aje.oxfordjournals.org/content/early/2011/08/24/aje.kwr200.full
Neurophysiological functioning of occasional and heavy cannabis users during THC
intoxication (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285765/
Legionnaires disease in cannabis smokers (link to download–2011)  https://www.researchgate.net/publication/47349274_Legionnaires_Disease_in_Cannabis_Smokers
Prolonged excretion half-life of 11-nor-9-carboxy-Δ⁹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment (1st page–2011) http://www.psychosomaticsjournal.com/article/S0033-3182%2810%2900028-9/abstract
Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21108863
The histopathology of drugs of abuse (abst–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2010.03728.x/abstract
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like  symptoms and psychological well-being (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21798112
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort  (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21749524
Cannabis use among military veterans after residential treatment for posttraumatic stress disorder (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21261407
Posttraumatic stress disorder and Cannabis use in a nationally representative sample  (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Cannabis use predicts shorter duration of untreated psychosis and lower levels of  negative symptoms in first-episode psychosis: a South African study (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21390411
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis (full–2012) http://jat.oxfordjournals.org/content/36/6/405.full
Prevalences of illicit drug use in people aged 50 years and over from two surveys (full–2012) http://ageing.oxfordjournals.org/content/41/4/553.long
Acute effects of THC on time perception in frequent and infrequent cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581701/
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376324/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full–2012) http://msj.sagepub.com/content/18/2/219.long
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456923/
Assessing topographical orientation skills in cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259701/?tool=pubmed
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use (full–2012) http://www.hindawi.com/journals/crim/2012/757696/
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the  National Health and Nutrition Examination Survey (NHANES) III (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289985/
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis  users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22731735
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Predictive model accuracy in estimating last Δ(9)-tetrahydrocannabinol (THC) intake
from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis
smokers administered subchronic oral THC (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0376871612000798
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis  Users and Controls (full–2013) http://www.frontiersin.org/Addictive_Disorders_and_Behavioral_Dyscontrol/10.3389/fpsyt.2013.00059/full
Single doses of THC and cocaine decrease proficiency of impulse control in heavy
cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws (full–2013) http://www.clinchem.org/content/59/3/519.full?sid=c00c9727-29e8-493c-83b8-456467e158b9
Cannabis use: a perspective in relation to the proposed UK drug-driving legislation (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1588/full
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957117/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Marijuana’s dose-dependent effects in daily marijuana smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23937597
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23952899
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947141/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic  frequent and occasional smokers (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
Urinary Cannabinoid Disposition in Occasional and Frequent Smokers: Is THC Glucuronide in Sequential Urine Samples a Marker of Recent Use in Frequent Smokers?  (full–2013) http://www.clinchem.org/content/60/2/361.long
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily  Marijuana Smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
A human laboratory study investigating the effects of quetiapine on marijuana  withdrawal and relapse in daily marijuana smokers (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465638/
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function (letter–2013) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0032-1316342
Creativity in cannabis-users and in drug addicts in maintenance treatment and in  rehabilitation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
Health outcomes associated with long-term regular cannabis and tobacco smoking (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501136
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24173827
Comparison of cannabinoid concentrations in oral fluid and whole blood between  occasional and regular cannabis smokers prior to and after smoking a cannabis joint  (abst–2013) https://link.springer.com/article/10.1007%2Fs00216-013-7412-1
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ijc.29036/full
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study (full–2014) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201407 -333OC#.VrA9xVJA44A
High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289662/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Mid-ventricular Variant Takotsubo Cardiomyopathy Associated with Cannabinoid  Hyperemesis Syndrome: A Case Report (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998230/
Cannabinoid hyperemesis should be recognised as an effect of chronic cannabis abuse  (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129569/
Blood levels do not predict behavioral or physiological effects of Δ⁹-
tetrahydrocannabinol in rhesus monkeys with different patterns of exposure (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251811/
Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent  Smokers Following Controlled Smoked Cannabis (full–2014)  http://www.clinchem.org/content/60/4/631.long
A survey of synthetic cannabinoid consumption by current cannabis users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048873/
Genetic predisposition to schizophrenia associated with increased use of cannabis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382963/
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
Early Withdrawal Effects in a Heavy Cannabis Smoker During Hemodialysis (1st page–2014) http://www.biologicalpsychiatryjournal.com/article/S0006-3223%2814%2900610-6/abstract
Imaging dopamine transmission parameters in cannabis dependence (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0278584613002340?via%3Dihub
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol
Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
Evaluation of Δ9 -tetrahydrocannabinol detection using DrugWipe5S® screening and  oral fluid quantification after Quantisal™ collection for roadside drug detection via a  controlled study with chronic cannabis users (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24753449
Detection Time for THC in Oral Fluid after Frequent Cannabis Smoking (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24819969
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308597/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full-2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum  Cannabis Smoking in Chronic Frequent Users (full–2015)  http://jat.oxfordjournals.org/content/39/8/580.long
Effects of quitting cannabis on respiratory symptoms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25837035
Responsible and controlled use: Older cannabis users and harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25911027
Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis  (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642772/
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during  sustained abstinence and correlation with psychomotor performance (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676741/
Naltrexone Maintenance Decreases Cannabis Self Administration and Subjective Effects in Daily Cannabis Smokers (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569951/
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full

Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults (abst–2015) http://link.springer.com/article/10.1007/s10865-015-9625-6
Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25698515
Head and neck cancer among marijuana users: A meta-analysis of matched case-control  studies (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0003996915300418
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26233612
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone  Maintenance Treatment: A French Prospective Study (abst–2015)  http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)00163-4/abstract
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2016) http://archinte.jamanetwork.com/article.aspx?articleid=2484906
Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Habituation of the startle reflex depends on attention in cannabis users (full–2016) http://bmcpsychology.biomedcentral.com/articles/10.1186/s40359-016-0158-8
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152482
Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/dar.12412/full
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes  (full–2016) http://www.ijdp.org/article/S0955-3959(16)30334-6/fulltext
Cannabis intake and intussusception: an accidental association? (download–2016)  http://scielo.isciii.es/pdf/diges/v109n2/nota_clinica3.pdf
Are We Using the Right Model of Cannabis Tolerance? (letter–2016)  http://www.jsad.com/doi/10.15288/jsad.2016.77.992
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer  Beware (1st page–2016) http://jama.jamanetwork.com/article.aspx?articleid=2526619
Retinal Ganglion Cell Dysfunction in Regular Cannabis Users Is the Evidence Strong
Enough to Consider an Association? (1st page–2016)  http://jamanetwork.com/journals/jamaophthalmology/fullarticle/2589166
Marijuana users do not have increased healthcare utilization: A National Health and
Nutrition Examination Survey (NHANES) study (1st page–2016)  http://www.ejinme.com/article/S0953-6205(16)30231-X/fulltext
Association Between Regular Cannabis Use and Ganglion Cell Dysfunction (abst–2016) http://jamanetwork.com/journals/jamaophthalmology/fullarticle/2589167
The effect of cannabis on regular cannabis consumers’ ability to ride a bicycle (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26739323
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by
Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385

Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
The effects of cannabis use on salience attribution: a systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866486
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
Environmental cues and attempts to change in daily cannabis users: An intensive  longitudinal study (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2900055-7/abstract
Longitudinal study of hippocampal volumes in heavy cannabis users (full–2017) http://journals.sagepub.com/doi/10.1177/0269881117718380
Spirometry findings among drug users in the Indonesian National Narcotics and illicit  drug Bureau Rehabilitation Center (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320827/
High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who  use illicit drugs in Vancouver, Canada (full–2017) http://www.ijdp.org/article/S0955-3959(17)30057-9/fulltext
Associations between Cannabis Use and Physical Health Problems in Early Midlife: A  Longitudinal Comparison of Persistent Cannabis versus Tobacco Users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a  Large Group of Chronic Cannabis Users (full–2017)  http://www.nature.com/npp/journal/vaop/ncurrent/full/npp201744a.html
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628563/
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628568/
Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent  Cannabidiol (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/
Effects of chronic Δ9-tetrahydrocannabinol treatment on Rho/Rho-kinase signalization  pathway in mouse brain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681306/
Frequency of Cannabis Use Among Primary Care Patients in Washington State (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769869/
Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of  Longitudinal Studies (full–2017) https://www.cambridge.org/core/journals/journal-of-the-international-neuropsychological-society/article/does-cannabis-use-causedeclines-in-neuropsychological-functioning-a-review-of-longitudinal-studies/83FC475C27D81917F8BA88254187BE97/core-reader
Decisional balance and processes of change in community-recruited with moderate-high
versus mild severity of cannabis dependence (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714356/
Trends in Lifetime Cannabis Use among Czech School-aged Children from 2002 to 2014  (link to download–2017) http://apps.szu.cz/svi/cejph/show_en.php?kat=archiv/2017-sup-09
Cannabis and lung. What we know and everything we don’t know yet (abst in English & French-2017) http://www.em-consulte.com/article/1173971/alertePM
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related  Behaviors and Working Memory (abst–2017)  http://www.ncbi.nlm.nih.gov/pubmed/27582345
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27936376
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and  cued-arousal among veterans who screen positive for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0306460317300072
Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28190094
Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV Infected  Persons Engaged in HIV Care (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28213820
Cannabis use and bone mineral density: NHANES 2007–2010 (abst–2017)  http://link.springer.com/article/10.1007%2Fs11657-017-0320-9
Subjective and physiological effects, and expired carbon monoxide concentrations in  frequent and occasional cannabis smokers following smoked, vaporized, and oral  cannabis administration (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30133-3/abstract
Marijuana Use and Self-reported Quality of Eyesight (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28422803
Corneal Endothelial Changes In Long Term Cannabinoid Users (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28427301
Blunted stress reactivity in chronic cannabis users (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4648-z
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in  Adolescent-Onset Heavy Cannabis Users: A Pilot Study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28641496
Daily associations between cannabis motives and consumption in emerging adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30278-8/fulltext
History of cannabis use is associated with altered gait (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30290-9/fulltext
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive  symptoms (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0278584617303676?via%3Dihub
Adolescent alcohol and cannabis use in Iceland 1995-2015 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28752650
Impact of Regular Cannabis Use on Biomarkers of Lower Urinary Tract Function (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827195
ABCB1 C3435T polymorphism is associated with tetrahydrocannabinol blood levels in  heavy cannabis users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28917442
Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29057200
Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and  anxiety-like activity are age- and strain-dependent in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0091305716302672?via%3Dihub
Incremental validity of estimated cannabis grams as a predictor of problems and  cannabinoid biomarkers: Evidence from a clinical trial (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30529-X/fulltext
Cognitive, physical, and mental health outcomes between long-term cannabis and  tobacco users (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304628?via%3Dihub
Association between increased EEG signal complexity and cannabis dependence (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29132831
Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing  in dependent marijuana users after 28 days of abstinence (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4803-6
Marijuana use among adults: Initiation, return to use, and continued use versus quitting  over a one-year follow-up period (full–2018)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30535-5/fulltext
The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana  Smokers in an Urban Public Hospital (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29327809
Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29161058
Cognitive, physical, and mental health outcomes between long-term cannabis and
tobacco users (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304628?via%3Dihub
Don’t Judge a Book by its Cover: Examiner Expectancy Effects Predict Neuropsychological Performance for Individuals Judged as Chronic Cannabis Users (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29342226
Postoperative Shivering Among Cannabis Users at a Public Hospital in Trinidad, West
Indies (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29362045
Cryptococcal meningitis in a daily cannabis smoker without evidence of  immuno-deficiency (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29374632

Does cannabis use predispose to chronic airflow obstruction? (full–2010) http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
“Bong lung” in cystic fibrosis: a case report (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998526/?tool=pmcentrez
Targeting the cannabinoid pathway limits the development of fibrosis and auto-immunity in a mouse model of systemic sclerosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Effects of cannabis on lung function: a population-based cohort study (full-2010) http://erj.ersjournals.com/content/35/1/42.long
DOSE-DEPENDENT EFFECTS ON VENTILATION AT REST INDUCED BY HIGH DOSES OF CANNABINOIDS IN RATS (abst–2010) http://www.maneyonline.com/doi/abs/10.1179/acb.2010.115
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20451365
Too many mouldy joints – marijuana and chronic pulmonary aspergillosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/?tool=pubmed
Legionnaires disease in cannabis smokers (link to download–2011)  https://www.researchgate.net/publication/47349274_Legionnaires_Disease_in_Cannabis_Smokers
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (link to download–2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Fatal alveolar haemorrhage following a “bang” of cannabis (abst in English, full in French–2011) http://www.em-consulte.com/rmr/article/651286/
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21279327
The histopathology of drugs of abuse (abst–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2010.03728.x/abstract
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation
in C57BL/6 mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case  report (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348083/
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22258232
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22652530
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657026/
Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction (full–2013) http://www.pnas.org/content/110/46/18710.full?sid=b685d344-5523-4371-a682-b03610d573e6
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23053725
Health outcomes associated with long-term regular cannabis and tobacco smoking (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501136
Synthetic Marijuana: Possibly A Lung’s Dying Breath (abst–2013) http://journal.publications.chestnet.org/article.aspx?articleid=1740537
Synthetic Cannabinoids as a Cause for Black Carbonaceous Bronchoalveolar Lavage  (abst–2013) http://journal.publications.chestnet.org/article.aspx?articleid=1740090
Diffuse Hemorrhagic Pulmonary Infiltrates: Unique Complication Of Synthetic Cannabinoid Abuse (abst–2013) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5043
The Synthetic Cannabinoid Ajulemic Acid Exerts Anti-Fibrotic Effects In Bleomycin Induced Pulmonary Fibrosis (abst–2013) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5649
Hemoptysis in a young man smoking cannabis (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23619207
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http://www.hindawi.com/journals/bmri/2014/971750/
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243853/
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study (full–2014) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201407-333OC#.VrA9xVJA44A
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25541904
Does cannabis smoking predispose to lung bulla formation? (full–2014) http://aan.sagepub.com/content/22/1/65.long
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5558
Acute Lung Injury Due To Synthetic Cannabis (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A6122
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population (full–2015) http://bjgp.org/content/65/631/e89

Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation (full–2015)  http://www.annemergmed.com/article/S0196-0644%2815%2900426-6/fulltext
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity (full–2015) http://www.hindawi.com/journals/cricc/2015/542490/
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376457/
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (full–2015)  http://jpet.aspetjournals.org/content/353/1/169.long
Effects of quitting cannabis on respiratory symptoms (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780250/
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (full–2015)  http://toxsci.oxfordjournals.org/content/147/2/535.long
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1 (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599364/
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
A New Threat: Synthetic Marijuana Associated Lung Disease (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4684
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema
by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
An outbreak of acute delirium from exposure to the synthetic cannabinoid ABCHMINACA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26555732
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the  benzoyl indole RCS-4 (full–2016)  http://link.springer.com/article/10.1007/s00204-016-1664-4/fulltext.html
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus  Infection in a Bovine Model (full–2016)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152913
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic  Cannabinoid Inhalation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156457/
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225803/
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Hypophosphatemia in Users of Cannabis (full–2016) http://www.ajkd.org/article/S0272-6386(16)30414-0/fulltext
A Curious Case of Inhalation Fever Caused by Synthetic Cannabinoid (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917070/
Acute effects of cannabis on breath-holding duration (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965168/
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell  Permeability through an Arachidonic Acid Metabolite (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000256
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyper-reactivity in NGF-induced inflammation in mouse airways (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26896777
Cannabinoids: Medical implications (abst–2016)  http://www.tandfonline.com/doi/abs/10.3109/07853890.2016.1145794?journalCode=iann20
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of  rat vagal lung C-fiber afferents (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27328978
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration (abst–2016) http://link.springer.com/article/10.1007%2Fs00011-016-0969-3
Alveolar haemorrhage following a cannabis water pipe (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27421143
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27595371
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell  Permeability through CB2 Receptors (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0006295216302878
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced  epileptic seizures in mice via quantitative mass spectrometry (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1388198116303092
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
Dangerous drugs: products containing synthetic chemicals (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26915246
Synthetic cannabinoid drug use as a cause or contributory cause of death (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26795398
Marijuana Use and Short-Term Outcomes in Patients Hospitalized for Acute Myocardial  (interview–2016) https://medicalresearch.com/heart-disease/marijuana-use-short-term-outcomes-patients-hospitalized-acute-myocardial/22914/
Spirometry findings among drug users in the Indonesian National Narcotics and illicit  drug Bureau Rehabilitation Center (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320827/
Associations between Cannabis Use and Physical Health Problems in Early Midlife: A  Longitudinal Comparison of Persistent Cannabis versus Tobacco Users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/
Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury  Attributable to the Use of Synthetic Cannabis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424589/
Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure (full–2017)  http://link.springer.com/article/10.1007%2Fs00216-017-0243-8
Cannabis-induced bullous lung disease leading to pneumothorax: Case report and  literature review (full–2017) http://journals.lww.com/md-journal/fulltext/2017/05120/Cannabis_induced_bullous_lung_disease_leading_to.76.aspx
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic  pulmonary fibrosis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396529/
Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced  pulmonary fibrosis in mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732744/
Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756717/
“Tree-in-Bloom”: Severe Acute Lung Injury Induced by Vaping Cannabis Oil (1st page–2017) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201612-974LE
Cannabis and lung. What we know and everything we don’t know yet (abst in English & French-2017) http://www.em-consulte.com/article/1173971/alertePM
Lung Disease Associated With Marijuana Use (abst in English & Spanish–2017)  http://www.sciencedirect.com/science/article/pii/S1579212917302240
Influence of history of cannabis smoking in selected donors on the outcomes of lung  transplantation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28077504
CB1 receptor-mediated respiratory depression by endocannabinoids (abst–2017)  http://www.sciencedirect.com/science/article/pii/S156990481730006X
What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis  sativa)? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28223891
Determinants of peripheral airway function in adults with and without asthma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397998
The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model (abst–2017)  http://link.springer.com/article/10.1007%2Fs10753-017-0568-7
Cannabis increased the risk of primary spontaneous pneumothorax in tobacco smokers: a case–control study (abst–2017)  https://academic.oup.com/ejcts/article-abstract/doi/10.1093/ejcts/ezx160/3866758/Cannabis-increased-the-risk-of-primaryspontaneous?redirectedFrom=fulltext
The case for cannabinoid CB1 receptors as a target for bronchodilator therapy for β-
agonist resistant asthma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28641517
AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28707493
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment  (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
Synthetic cannabinoid induced acute respiratory depression: Case series and literature  review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28794966
Unintentional Cannabis Ingestion in Children: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28888560
Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human  subjects and mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28992427
Endocannabinoid engagement of CB2 regulates RSV-induced immunity (link to PDF–2018) http://www.tandfonline.com/doi/abs/10.1080/21505594.2017.1421830
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567

Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis  (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046

Chronic cannabinoid administration lowers viral replication in lymph nodes of SIV  infected Rhesus macaques (abst-2010)  http://www.fasebj.org/content/24/1_Supplement/752.6.abstract?sid=fbdd98b1-1fa3-4724-b0c2-afc89e3b0c46
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte  chemotaxis (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011)  http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by  inhibiting matrix metalloproteinase 9 expression (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T  lymphocytes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22823387
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft  Rejection, the Mixed Lymphocyte Reaction (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor  Protein by Human Peripheral Blood Leukocytes (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte  compartment (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235638/
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in
lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23793235
Human lung-resident macrophages express CB1 and CB2 receptors whose activation  inhibits the release of angiogenic and lymphangiogenic factors (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787289/
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid  leukemia with lymphoid differentiation patterns (full–2016)  http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of  patients with Dravet syndrome (full–2016)  http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of  patients with Dravet syndrome (full–2016)  http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is  correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is  correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Innate lymphoid cells in asthma: cannabinoids on the balance (full–2017)  http://onlinelibrary.wiley.com/doi/10.1111/all.13145/epdf
Metabolic gatekeeper function of B-lymphoid transcription factors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621518/
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the  intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator  levels in mice via CB2 receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28828742
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167227